Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (EILAT IX)

Meir Bialer, Svein I. Johannessen, René H. Levy, Emilio Perucca, Torbjörn Tomson, H. Steve White

Research output: Contribution to journalArticlepeer-review


The Ninth Eilat Conference on New Antiepileptic Drugs (AEDs)-EILAT IX, took place in Sitges, Barcelona from the 15th to 19th of June 2008. Over 300 basic scientists, clinical pharmacologists and neurologists from 25 countries attended the conference, whose main themes included old and new AEDs in generalized epilepsies, novel formulations and routes of administration of AEDs, common targets and mechanisms of action of drugs for treating epilepsy and other central nervous system (CNS) disorders, and opportunities and perspectives in new AED discovery. Consistent with previous formats of this conference, a large part of the programme was devoted to a review of AEDs in development, as well as updates on AEDs introduced since 1989. Unlike previous EILAT manuscripts, the current (EILAT IX) manuscript focuses only on the preclinical and clinical pharmacology of AEDs that are currently in development. These include brivaracetam, carisbamate (RWJ-333369), 2-deoxy-d-glucose, eslicarbazepine acetate (BIA-2-093), ganaxolone, huperzine, JZP-4, lacosamide, NAX-5055, propylisopropylacetamide (PID), retigabine, T-2000, tonabersat, valrocemide and YKP-3089. The CNS efficacy of these compounds in anticonvulsant animal models as well as other disease model systems are presented in first and second tables and their proposed mechanisms of action are summarized in the third table.

Original languageEnglish
Pages (from-to)1-43
Number of pages43
JournalEpilepsy Research
Issue number1
Publication statusPublished - Jan 2009


  • Antiepileptic drugs
  • Clinical trials
  • Conference
  • Drug development
  • Epilepsy
  • Pharmacology

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology


Dive into the research topics of 'Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (EILAT IX)'. Together they form a unique fingerprint.

Cite this